Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ritva, Ylitalo"'
Publikováno v:
Arzneimittelforschung. 55:160-166
The aim of this study was to compare the influences of antianginal drugs such as mononitrate, β-blocker and calcium channel blocker on cardiovascular responsiveness to orthostasis. The responses to passive or-thostasis (tilt provocation at 60° for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdea153f792c65169fbc14160ef61a05
https://doi.org/10.1055/s-0031-1296838
https://doi.org/10.1055/s-0031-1296838
Publikováno v:
Arzneimittelforschung. 55:205-211
To compare the acute effects of the β-blocker propranolol (CAS 525-66-6), β + α 1 -blocker carvedilol (CAS 72956-09-3) and α 1 -blocker tamsulosin (CAS 106463-17-6) on the cardiovascular responses to passive orthostasis. The responses to passive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3df288fcd97632b4cbfd8b87989bb398
https://doi.org/10.1055/s-0031-1296846
https://doi.org/10.1055/s-0031-1296846
Autor:
Erkki Wuolijoki, Riikka Rontu, Terho Lehtimäki, Saara Metso, Pauli Ylitalo, Ritva Ylitalo, Matti Nikkil
Publikováno v:
Basic Toxicology. 97:98-103
Chitosan is a deacetylated product of chitin. Microcrystalline form of chitosan has a large adsorption area claimed to decrease gastrointestinal absorption of cholesterol. However, the long-term effect of chitosan on plasma lipids is variable, the av
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fe053912257658bf5236c6516a18df4
https://doi.org/10.1111/j.1742-7843.2005.pto_111.x
https://doi.org/10.1111/j.1742-7843.2005.pto_111.x
Publikováno v:
European Urology. 47:340-345
To compare in details the effects of urologically used alpha(1)-blockers alfuzosin and tamsulosin on the cardiovascular responses to passive orthostasis.The responses to passive orthostasis (tilt provocation at 60 degrees for 8 min) were measured in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98f40c9932dde7aa42533e4e96b5ffa9
https://doi.org/10.1016/j.eururo.2004.11.002
https://doi.org/10.1016/j.eururo.2004.11.002
Publikováno v:
European Journal of Clinical Pharmacology. 59:741-746
To evaluate the long-term effect of microcrystalline chitosan (MCC) on plasma lipids, especially the concentration of low-density lipoprotein (LDL) cholesterol, in subjects with a moderately increased concentration of plasma total cholesterol. A tota
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::173e80b85b4db3b5f326f4412a157d02
https://doi.org/10.1007/s00228-003-0691-2
https://doi.org/10.1007/s00228-003-0691-2
Publikováno v:
Pharmacology & Toxicology. 90:139-143
Bisphosphonates inhibit the development of experimental atherosclerosis and decrease the intima-media thickness of human carotid artery. Since arterial macrophages have a key role in atherogenesis, we studied whether clodronate, an antiatherogenic bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e6f18996622b0120dabba2792f56c1c
https://doi.org/10.1034/j.1600-0773.2002.900305.x
https://doi.org/10.1034/j.1600-0773.2002.900305.x
Publikováno v:
General Pharmacology: The Vascular System. 35:219-224
beta-Adrenoceptor blockers with disparate properties may have differential influences on arterial pulse wave velocity (PWV). Therefore, influences of single medium doses of bisoprolol, propranolol and celiprolol on PWV were compared in healthy subjec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b189b54da702e825734768e8cf07a6a
https://doi.org/10.1016/s0306-3623(01)00109-4
https://doi.org/10.1016/s0306-3623(01)00109-4
Publikováno v:
Journal of Laboratory and Clinical Medicine. 127:200-206
Clodronate, etidronate, and pamidronate are highly hydrophilic bisphosphonates used for the treatment of bone resorption and hypercalcemia. They also inhibit the development of experimental atherosclerosis without influencing serum cholesterol level.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad1fc38058fa7bece80e38aeaa14df82
https://doi.org/10.1016/s0022-2143(96)90079-7
https://doi.org/10.1016/s0022-2143(96)90079-7
Publikováno v:
Arzneimittel-Forschung. 55(4)
To compare the acute effects of the beta-blocker propranolol (CAS 525-66-6), beta + alpha1-blocker carvedilol (CAS 72956-09-3) and alpha1-blocker tamsulosin (CAS 106463-17-6) on the cardiovascular responses to passive orthostasis.The responses to pas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e2dc98a13e30e8f6f3e3c7aad7d8838
https://pubmed.ncbi.nlm.nih.gov/15901043
https://pubmed.ncbi.nlm.nih.gov/15901043
Autor:
Ritva, Ylitalo, Mika, Kähönen, Tuomo, Nieminen, Tiit, Kööbi, Pauli, Ylitalo, Väinö, Turjanmaa
Publikováno v:
Arzneimittel-Forschung. 55(3)
The aim of this study was to compare the influences of antianginal drugs such as mononitrate, beta-blocker and calcium channel blocker on cardiovascular responsiveness to orthostasis.The responses to passive orthostasis (tilt provocation at 60 degree
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ed20e35a47460363a50a6ec708059130
https://pubmed.ncbi.nlm.nih.gov/15819388
https://pubmed.ncbi.nlm.nih.gov/15819388